Consistent with this notion, genetically-mediated silencing of the human SOS2 gene by means of miRNAs or CRISPR/Cas9 also produces significant therapeutic benefits in different in vitro models, including human tumor cell lines (Table 2). Here, SOS2 is linked to neoplasm.